First Horizon Advisors’s Coherus Oncology CHRS Stock Holding History

First Horizon Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-482	Closed	-$8K	–	1799
2021 Q4	$8K	Hold	482	–	–	﹤0.01%	1588
2021 Q3	$8K	Hold	482	–	–	﹤0.01%	1596
2021 Q2	$7K	Buy	482 +6	+1%	+$85	﹤0.01%	1434
2021 Q1	$7K	Sell	476 -42	-8%	-$713	﹤0.01%	1381
2020 Q4	$9K	Buy	518 +84	+19%	+$1.5K	﹤0.01%	1087
2020 Q3	$8K	Hold	434	–	–	﹤0.01%	1051
2020 Q2	$8K	Buy	+434	New	+$7.35K	﹤0.01%	1062

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

First Horizon Advisors's CHRS Position: Q1 2022 in Review

First Horizon Advisors sold out of Coherus Oncology (CHRS) in Q1 2022, closing a stake of 482 shares — an estimated $8K sold.

First Horizon Advisors first reported a position in CHRS in Q2 2020 and held it in 7 quarters. The position peaked at $9K in Q4 2020. 183 funds tracked by Wall St. Rank hold CHRS as of Q1 2022.

First Horizon Advisors reported no remaining Coherus Oncology position as of Q1 2022 after selling out during the quarter.
First Horizon Advisors sold 482 Coherus Oncology shares in Q1 2022, an estimated $8K.
First Horizon Advisors first reported a position in Coherus Oncology in Q2 2020 and held it in 7 quarters.
First Horizon Advisors's Coherus Oncology position peaked at $9K in Q4 2020.
183 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2022.

Based on First Horizon Advisors's 13F filing for Q1 2022, filed 10 May 2022.